Next Article in Journal
Diamond Nanoparticles Downregulate Expression of CycD and CycE in Glioma Cells
Next Article in Special Issue
Silibinin Downregulates the NF-κB Pathway and NLRP1/NLRP3 Inflammasomes in Monocytes from Pregnant Women with Preeclampsia
Previous Article in Journal
The Anti-Inflammatory Role of Mannich Curcuminoids; Special Focus on Colitis
Previous Article in Special Issue
Silybin Modulates Collagen Turnover in an In Vitro Model of NASH
Article Menu
Issue 8 (April-2) cover image

Export Article

Open AccessArticle

A Water-Soluble Microencapsulated Milk Thistle Extract as Active Ingredient for Dermal Formulations

Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano (SA), Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Dominique Delmas
Molecules 2019, 24(8), 1547; https://doi.org/10.3390/molecules24081547
Received: 30 March 2019 / Revised: 12 April 2019 / Accepted: 17 April 2019 / Published: 19 April 2019
(This article belongs to the Special Issue Silymarin and Derivatives: From Biosynthesis to Health Benefits)
  |  
PDF [1743 KB, uploaded 19 April 2019]
  |  

Abstract

The choice of formulation is often of crucial importance in order to obtain a pharmaceutical product for the administration of poorly soluble drugs. Recently, a new water-soluble microparticulate powder form (MTE-mp) for the oral administration of a high functionality/low solubility silymarin rich milk thistle extract (MTE) has been developed. Findings showed that extract-loaded microparticles by spray-drying were produced with high and reproducible yields and encapsulation efficiency. The in vitro dissolution and permeation rates of silymarin were dramatically improved with respect to the raw material, and also enhanced the silymarin anti-inflammatory abilities. Given these successful results, the new MTE-mp delivery system has been proposed as an active ingredient for dermal applications. The aim of this research was the design and development of two topical formulations, hydrogel and emulgel (O/W emulsion), containing the MTE-mp delivery system or MTE raw extract. All the formulations were compared to each other in terms of handling and incorporation amount of the active ingredient during the productive process. Moreover, the addition to the emulgel of lecithin (L) as enhancer of permeation was tested. The MTE-mp ingredient that resulted was stable and more-easily incorporated both in hydrogel and emulgel than raw MTE extract, obtaining the best permeation profile for MTE-mp from emulgel with the addition of L. The obtained results confirm that the MTE-mp system could be used as a stable, water-soluble, and easy-handling functional ingredient, giving the opportunity to develop new strategies for MTE delivery in health products. View Full-Text
Keywords: silymarin; delivery system; hydrogel and emulgel; lecithin; stability and in vitro permeation profile silymarin; delivery system; hydrogel and emulgel; lecithin; stability and in vitro permeation profile
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Esposito, T.; Sansone, F.; Russo, P.; Picerno, P.; Aquino, R.P.; Gasparri, F.; Mencherini, T. A Water-Soluble Microencapsulated Milk Thistle Extract as Active Ingredient for Dermal Formulations. Molecules 2019, 24, 1547.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top